Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort

NCT04344756 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

808

Enrollment

OTHER

Sponsor class

Conditions

COVID19 Pneumonia

Interventions

DRUG: Tinzaparin or unfractionated heparin

Sponsor

Assistance Publique - Hôpitaux de Paris